
New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPVjBaSjdRMjdDNE0teEZ4N1dsazY4VVNjNVdVekVCT2tZb0VwOVE5OWFqY2E2MVFiLUR4YWpSb1JielNOSW13OUV5THpFa0FldDNva0xvUWg0RGlYSmV2ZzlxazlnNVJGRFU3bm53QnlXUU1jNVVVMnl1R2JpenlhbF9TdEp3TGt5eHJ0LXA2WmtqaUFtMkVXa0U0aGV6NjBVS3B5dURxOWdicXhmblBKeGdtRmxUekJmMHNsbnExcw?oc=5" target="_blank">New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit</a>&nbsp;&nbsp;<font color="#6f6f6f">STAT</font>
